Real-world effectiveness of ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in patients with hepatitis C virus genotype 1 or 4 infection: A meta-analysis.

H WedemeyerA CraxíE ZuckermanD DieterichR FlisiakStuart Keith RobertsA PangerlZ ZhangM MartinezY BaoJ-L Calleja

Published in: Journal of viral hepatitis (2017)

Real-world SVR12 rates for OBV/PTV/r±DSV±RBV were consistently high across HCV GT1 and four irrespective of cirrhosis status or prior HCV treatment experience, confirming effectiveness within a diverse patient population across multiple cohorts and countries.

Keyphrases

hepatitis c virus
human immunodeficiency virus
randomized controlled trial
systematic review
case report
antiretroviral therapy
combination therapy